Diversify Advisory Services LLC Takes Position in The Cooper Companies, Inc. $COO

Diversify Advisory Services LLC purchased a new stake in The Cooper Companies, Inc. (NASDAQ:COOFree Report) in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm purchased 24,242 shares of the medical device company’s stock, valued at approximately $1,704,000.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in COO. Avalon Trust Co acquired a new position in shares of Cooper Companies during the 2nd quarter valued at about $25,000. Root Financial Partners LLC raised its stake in Cooper Companies by 104.5% during the fourth quarter. Root Financial Partners LLC now owns 317 shares of the medical device company’s stock worth $26,000 after purchasing an additional 162 shares during the period. SJS Investment Consulting Inc. raised its stake in Cooper Companies by 107.5% during the first quarter. SJS Investment Consulting Inc. now owns 361 shares of the medical device company’s stock worth $26,000 after purchasing an additional 187 shares during the period. Elevation Wealth Partners LLC boosted its holdings in Cooper Companies by 1,136.4% in the 2nd quarter. Elevation Wealth Partners LLC now owns 408 shares of the medical device company’s stock valued at $29,000 after purchasing an additional 375 shares during the last quarter. Finally, J.Safra Asset Management Corp acquired a new position in Cooper Companies in the 2nd quarter valued at about $32,000. Institutional investors and hedge funds own 24.39% of the company’s stock.

Cooper Companies Stock Performance

NASDAQ:COO opened at $76.73 on Thursday. The company has a fifty day simple moving average of $71.59 and a two-hundred day simple moving average of $71.16. The company has a quick ratio of 0.78, a current ratio of 1.27 and a debt-to-equity ratio of 0.23. The Cooper Companies, Inc. has a 52 week low of $58.89 and a 52 week high of $89.83. The company has a market cap of $14.96 billion, a price-to-earnings ratio of 65.03, a price-to-earnings-growth ratio of 1.98 and a beta of 0.83.

Cooper Companies (NASDAQ:COOGet Free Report) last announced its quarterly earnings results on Thursday, June 4th. The medical device company reported $1.21 EPS for the quarter, beating the consensus estimate of $1.10 by $0.11. The company had revenue of $1.08 billion for the quarter, compared to analyst estimates of $1.05 billion. Cooper Companies had a net margin of 5.57% and a return on equity of 10.88%. The firm’s revenue was up 7.9% on a year-over-year basis. During the same period in the prior year, the firm posted $0.96 earnings per share. Cooper Companies has set its FY 2026 guidance at 4.580-4.660 EPS. As a group, equities analysts anticipate that The Cooper Companies, Inc. will post 4.63 earnings per share for the current fiscal year.

Analyst Ratings Changes

Several research analysts recently weighed in on COO shares. Wells Fargo & Company reiterated a “sell” rating and issued a $66.00 price objective (down from $82.00) on shares of Cooper Companies in a research report on Friday, June 5th. Needham & Company LLC reduced their target price on Cooper Companies from $101.00 to $86.00 and set a “buy” rating on the stock in a research report on Friday, June 5th. JPMorgan Chase & Co. decreased their price target on Cooper Companies from $80.00 to $71.00 and set a “neutral” rating on the stock in a research note on Friday, June 5th. Weiss Ratings cut Cooper Companies from a “hold (c-)” rating to a “sell (d)” rating in a report on Monday, June 8th. Finally, Mizuho set a $85.00 price objective on Cooper Companies and gave the stock an “outperform” rating in a research report on Thursday, June 4th. One equities research analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating, six have issued a Hold rating and three have issued a Sell rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of “Hold” and an average price target of $81.64.

Check Out Our Latest Stock Report on COO

About Cooper Companies

(Free Report)

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.

Recommended Stories

Want to see what other hedge funds are holding COO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Cooper Companies, Inc. (NASDAQ:COOFree Report).

Institutional Ownership by Quarter for Cooper Companies (NASDAQ:COO)

Receive News & Ratings for Cooper Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies and related companies with MarketBeat.com's FREE daily email newsletter.